22 Dec 2009 08:43
Omega Diagnostics Group PLC
(the "Company")
Directorate Change
Omega, the AIM listed medical diagnostics company, announces that Geoff Gower will join the Board as an Executive Director with immediate effect.
Geoff Gower, aged 54, is currently Managing Director of Genesis Diagnostics Ltd and Cambridge Nutritional Sciences Ltd. Prior to this he was the owner/director of Camsensia Ltd, a diagnostics consultancy business primarily involved in strategic business development.
Geoff Gower has held positions of Operations Director, Managing Director and General Manager with companies such as Dako and Oxoid, both significant companies in the In Vitro Diagnostics (IVD) Sector. During a career spanning 26 years in the IVD arena he has served on several Boards since 1991. Geoff Gower has experience of overseeing the growth of diagnostic companies from both operations and general management perspectives.
Andrew Shepherd, the Company's Chief Executive said:
"We are very pleased to welcome Geoff to the Board and with his appointment he brings a wealth of experience to the Group which will be beneficial to the Group's future expansion plans."
For further enquiries please contact
| Omega Diagnostics Group PLC | Tel: 01259 763 030 |
| Andrew Shepherd, Chief Executive | |
| Kieron Harbinson, Group Finance Director | www.omegadiagnostics.com |
| Cenkos Securities plc | Tel: 020 7397 8900 |
| Nicholas Wells Camilla Hume Ian Soanes | chume@cenkos.com isoanes@cenkos.com |
| Walbrook PR Limited | Tel: 020 7933 8780 |
| Paul McManus | Paul.McManus@walbrookpr.com |
Save as disclosed below there are no additional disclosures to be made in accordance with paragraph (g) of Schedule 2 of the AIM rules.
Geoff Gower has been a director of the following companies during the last five years:
Camsensia Ltd
IQ Bio Ltd
Oxoid (Ely) Ltd
Novo Nordisk Diagnostics Ltd
Doublecape Ltd
Doublecape Holding Ltd
ODX.L (ODX)